DekaBank Deutsche Girozentrale’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,250
Closed -$323K 1395
2022
Q1
$323K Sell
3,250
-19,371
-86% -$496K ﹤0.01% 1135
2021
Q4
$1.03M Buy
22,621
+1,841
+9% +$110K ﹤0.01% 932
2021
Q3
$1.47M Buy
20,780
+13,876
+201% +$1M ﹤0.01% 801
2021
Q2
$552K Buy
6,904
+2,104
+44% +$139K ﹤0.01% 1054
2021
Q1
$227K Hold
4,800
﹤0.01% 1164
2020
Q4
$195K Buy
+4,800
New +$189K ﹤0.01% 1186

Other funds holding NBP

DekaBank Deutsche Girozentrale's NBP Position: Q2 2022 in Review

DekaBank Deutsche Girozentrale sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 3,250 shares — an estimated $323K sold.

DekaBank Deutsche Girozentrale first reported a position in NBP in Q4 2020 and held it in 6 quarters. The position peaked at $1.47M in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • DekaBank Deutsche Girozentrale reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 3,250 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $323K.
  • DekaBank Deutsche Girozentrale first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's NovaBridge Biosciences American Depositary Shares position peaked at $1.47M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.